GH Guardant Health, Inc.
Guardant Health, Inc. (GH) is expected to report earnings on October 29, 2026, after the market close. The consensus earnings estimate is a loss of $0.65 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -3.3% since its last earnings release on July 30, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Guardant Health, Inc.
Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary tests, vast data sets and advanced analytics.
Sector
Healthcare
Industry
Medical Labs & Research